4/A

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: January 18, 2011
Period of Report: August 25, 2008
Accession Number: 0001437749-11-000320

View Document ↗ View on SEC.gov ↗